To access this element change to forms mode OFF
Grant Award View - GA58431
Rational clinical trial design and treatment selection for advanced...
GA ID:
GA58431
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
23-Sep-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$1,504,485.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Rational clinical trial design and treatment selection for advanced cancer patients.
Purpose:
Highly effective cancer drugs that enhance a patient’s natural immune anti-tumoral response, called immunotherapies, have revolutionised cancer care. However, more than 50 percent of treated patients are still dying from their cancer and they need to be identified for new treatments. This research will personalise the selection of immunotherapy drugs to a patient’s specific tumour biology. This personalised drug selection will increase the cure rates of cancer patients.
GO ID:
GO Title:
Investigator Grants 2019
Internal Reference ID:
GNT1174325
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA